InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Maha Katabi, Director, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 6 open-market SEC Form 4 transactions: 3 purchases worth $13.2M and 3 sales worth $31.9M, reported from Feb 10, 22 to Mar 25, 24. Over this period they have been a mix of buying and selling.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 25, 24 | VERAVera Therapeutics, Inc. | SELL | 340.0K | $40.50 | $13.8M |
| Mar 22, 24 | VERAVera Therapeutics, Inc. | SELL | 413.4K | $40.51 | $16.7M |
| Mar 21, 24 | VERAVera Therapeutics, Inc. | SELL | 32.8K | $46.18 | $1.4M |
| Jan 30, 24 | VERAVera Therapeutics, Inc. | BUY | 161.3K | $31.00 | $5.0M |
| Sep 19, 23 | RYZBRayzeBio, Inc. | BUY | 236.1K | $18.00 | $4.2M |
| Feb 10, 22 | VERAVera Therapeutics, Inc. | BUY | 266.7K | $15.00 | $4.0M |